Lannett Ondansetron injection receives FDA approval
By New Statesman - 09 August 11:30

Anti-nausea drug rubberstamped by US regulator.

GSK signs drug formulation patents agreement with Vectura
By New Statesman - 09 August 11:26

Pharma giant signs deal on respiratory medicines.

GSK's new compound to fight drug-resistant bacteria
By New Statesman - 05 August 14:06

Discovery may lead to new ways of tackling hospital superbugs.

Cornerstone buys license to Cough Company intellectual property
By New Statesman - 03 August 12:21

North Carolina pharma group aims to expand range of medicines with acquisition.

Bilcare to buy INEOS Global Films business
By New Statesman - 03 August 12:12

Packaging research groups buys up production outfit for €100m

Conatus Pharma takes over Pfizer subsidiary Idun
By New Statesman - 02 August 12:05

CEO says deal will expand company's development of oncology drugs.

LAB Research signs PRA with Japanese pharma firm
By New Statesman - 28 July 13:53

Canadian research organisation will offer full line of services to far eastern pharmaceutical compan

Gilead Sciences Q2 revenues up 17%
By New Statesman - 23 July 11:42

Biopharmaceutical company cheers second quarter success thanks mainly to its abtiviral products

Reckitt may sell off Scholl unit after SSL takeover
By New Statesman - 22 July 16:17

SSL shares up 33 per cent following announcement, suggesting possible counter-bid.

Reckitt Benckiser to buy SSL in £2.5bn all-cash bid
By New Statesman - 21 July 16:32

Redundancies expected as household goods firm expands.

Teva and Sun Pharma lose US court case
By New Statesman - 19 July 15:19

Pharamceutical companies' attempt to appeal verdict over stomach acid drug a failure.

GSK to take £1.57bn hit in legal settlement charges
By New Statesman - 16 July 15:28

Pharmaceutical company to pay out for case settlements spanning last 20 years

Elan agrees to settle Zonegran sales
By New Statesman - 16 July 13:44

Investigation of sales and marketing expects Elan subsidiary - Elan Pharmaceuticals - to plead guilt

US regulators suggest changes to Avandia, but no ban
By New Statesman - 15 July 15:15

Patients are thought to have been previously misled about the side effects of the diabetes drug.

Neptune Q1 revenue surges 45%
By New Statesman - 15 July 13:50

Pharmaceutical product manufacturer posts rapid turnaround after factory investment.

GlaxoSmithKline and US regulators face-off over diabetes pill
By New Statesman - 13 July 14:03

GlaxoSmithKline has been accused of trying to intimidate scientists researching the risks of the dru

Indian pharma company transfers new drug unit to research firm
By New Statesman - 06 July 13:03

Ranbaxy Laboratories moves R&D section into Daiichi Sankyo in research restructuring.

Paris merge of anti-infective research teams
By New Statesman - 02 July 12:03

Biocitech announces the merger of the anti-infective research teams of Pharma Omnium International o

AstraZeneca to collaborate with non-profit group on anti-malarial drugs
By New Statesman - 30 June 11:56

MMV to have access to pharma group's compound library.

Pharmaceutical maker recalls mouthwash bottles in US, Canada
By New Statesman - 29 June 12:30

Proctor & Gamble says some bottles of Scope mouthwash have defective child-resistant caps.

Axxess Pharma signs Letter of Intent to acquire Canadian pharma manufacturer
By New Statesman - 28 June 11:53

Company set to expand share of Canadian market

Autism treatment study completed
By New Statesman - 25 June 12:45

Compound successfully modelled on rats.

Ablynx opens new R&D facility
By New Statesman - 24 June 13:46

Pharma group expands research operation

Pharmaceutical giant to create clinical tests with diagnostic company
By New Statesman - 23 June 11:57

Global pharma company Bristol-Myers Squibb will develop new tests for its products with Saladax Biom

Alliance Medical needs £150m to avoid bankruptcy
By New Statesman - 22 June 16:21

The company's owner, Dubai International Capital, in talks with lenders over the rescue.

German biotech company helps US Army combat bio-agents
By New Statesman - 21 June 12:44

Proteo will provide US Army with research to create new therapies for disease-causing biological age

Kyoto University to utilize real-time smart chip system in research
By New Statesman - 21 June 12:33

System from WaferGen Biosystems will help Kyoto scientists identify progress and treatment of diseas

Bristol-Myers Squibb signs agreements with Icon, Parexel
By New Statesman - 15 June 13:43

Pharmaceutical giant will expand its clinical studies capability with the new partners.

Pfizer establishes rare disease research unit
By New Statesman - 15 June 13:32

Section will address treating diseases affecting less than 200K people.

Merge Healthcare to launch new solution for clinical trials imaging
By New Statesman - 14 June 13:53

Health care company claims solution will streamline the medical imaging analysis process and make it

Pages